Anemia is a common complication of CKD, contributing to fatigue, cardiovascular risk, and reduced quality of life. Effective management includes iron supplementation, erythropoiesis-stimulating agents (ESAs), and newer therapies like HIF-PH inhibitors. Optimizing hemoglobin levels while minimizing risks is crucial for improving patient outcomes. In this session, Dr. Sajith Narayanan will discuss the latest advancements and practical strategies for managing anemia in CKD.